Aquatic Capital Management’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $992K | Sell |
31,484
-684
| -2% | -$21.6K | 0.02% | 647 |
|
2025
Q1 | $1.05M | Buy |
32,168
+31,342
| +3,794% | +$1.03M | 0.03% | 590 |
|
2024
Q4 | $29.9K | Sell |
826
-1,974
| -71% | -$71.4K | ﹤0.01% | 1216 |
|
2024
Q3 | $87.3K | Buy |
+2,800
| New | +$87.3K | ﹤0.01% | 939 |
|
2024
Q1 | – | Sell |
-4,700
| Closed | -$136K | – | 1624 |
|
2023
Q4 | $136K | Buy |
+4,700
| New | +$136K | ﹤0.01% | 940 |
|
2023
Q3 | – | Sell |
-19,600
| Closed | -$589K | – | 1633 |
|
2023
Q2 | $589K | Buy |
+19,600
| New | +$589K | 0.03% | 417 |
|
2022
Q3 | – | Sell |
-200
| Closed | -$6K | – | 1532 |
|
2022
Q2 | $6K | Buy |
+200
| New | +$6K | ﹤0.01% | 1035 |
|
2022
Q1 | – | Sell |
-100
| Closed | -$3K | – | 1503 |
|
2021
Q4 | $3K | Buy |
+100
| New | +$3K | 0.01% | 1018 |
|